406 related articles for article (PubMed ID: 19801974)
1. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer.
Gumireddy K; Li A; Gimotty PA; Klein-Szanto AJ; Showe LC; Katsaros D; Coukos G; Zhang L; Huang Q
Nat Cell Biol; 2009 Nov; 11(11):1297-304. PubMed ID: 19801974
[TBL] [Abstract][Full Text] [Related]
2. Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.
Ali A; Bhatti MZ; Shah AS; Duong HQ; Alkreathy HM; Mohammad SF; Khan RA; Ahmad A
J Biol Chem; 2015 Aug; 290(35):21336-51. PubMed ID: 25911104
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-function of mutant p53: mutant p53 enhances cancer progression by inhibiting KLF17 expression in invasive breast carcinoma cells.
Ali A; Shah AS; Ahmad A
Cancer Lett; 2014 Nov; 354(1):87-96. PubMed ID: 25111898
[TBL] [Abstract][Full Text] [Related]
4. DJ-1 upregulates breast cancer cell invasion by repressing KLF17 expression.
Ismail IA; Kang HS; Lee HJ; Kim JK; Hong SH
Br J Cancer; 2014 Mar; 110(5):1298-306. PubMed ID: 24504364
[TBL] [Abstract][Full Text] [Related]
5. Suppressed Krüppel‑like factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma.
Ye WC; Gao L; Huang J; Fang XM; Xie G
Mol Med Rep; 2014 Oct; 10(4):2087-92. PubMed ID: 25109837
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
Jiang X; Shen TY; Lu H; Shi C; Liu Z; Qin H; Wang F
Oncol Rep; 2019 Nov; 42(5):2117-2129. PubMed ID: 31545467
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 17, a novel tumor suppressor: its low expression is involved in cancer metastasis.
Zhou S; Tang X; Tang F
Tumour Biol; 2016 Feb; 37(2):1505-13. PubMed ID: 26662959
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of metastatic [Id]entity by KLF17.
Iwanicki MP; Brugge JS
Genome Biol; 2009; 10(11):244. PubMed ID: 19951400
[TBL] [Abstract][Full Text] [Related]
9. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
10. 2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells.
Ismail IA; Kang HS; Lee HJ; Chang H; Yun J; Lee CW; Kim NH; Kim HS; Yook JI; Hong SH; Kwon BM
Breast Cancer Res Treat; 2013 Feb; 137(3):697-708. PubMed ID: 23283523
[TBL] [Abstract][Full Text] [Related]
11. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.
Yang J; Mani SA; Donaher JL; Ramaswamy S; Itzykson RA; Come C; Savagner P; Gitelman I; Richardson A; Weinberg RA
Cell; 2004 Jun; 117(7):927-39. PubMed ID: 15210113
[TBL] [Abstract][Full Text] [Related]
12. Low expression of KLF17 is associated with tumor invasion in esophageal carcinoma.
Li S; Qin X; Cui A; Wu W; Ren L; Wang X
Int J Clin Exp Pathol; 2015; 8(9):11157-63. PubMed ID: 26617836
[TBL] [Abstract][Full Text] [Related]
13. Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.
Wang X; Zheng M; Liu G; Xia W; McKeown-Longo PJ; Hung MC; Zhao J
Cancer Res; 2007 Aug; 67(15):7184-93. PubMed ID: 17671186
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
15. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer.
DiMeo TA; Anderson K; Phadke P; Fan C; Perou CM; Naber S; Kuperwasser C
Cancer Res; 2009 Jul; 69(13):5364-73. PubMed ID: 19549913
[TBL] [Abstract][Full Text] [Related]
16. Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
Kijewska M; Viski C; Turrell F; Fitzpatrick A; van Weverwijk A; Gao Q; Iravani M; Isacke CM
Breast Cancer Res; 2019 Jan; 21(1):4. PubMed ID: 30642388
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
[TBL] [Abstract][Full Text] [Related]
18. Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer.
Dong P; Kaneuchi M; Xiong Y; Cao L; Cai M; Liu X; Guo SW; Ju J; Jia N; Konno Y; Watari H; Hosaka M; Sudo S; Sakuragi N
Carcinogenesis; 2014 Apr; 35(4):760-8. PubMed ID: 24220291
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression.
Liu X; Feng R
Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):496-501. PubMed ID: 20705589
[TBL] [Abstract][Full Text] [Related]
20. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
